about
A Longitudinal Assessment of Tumor Evolution in Patients With Brain CancerProcure Tumor and Initiate Melanoma Tumor-Reactive Tumor InfiltrationTrial of pIL-12 Electroporation Malignant MelanomaMinimally Invasive Groin Dissection for MelanomaIrofulven in Treating Patients With Stage IV MelanomaMarimastat in Treating Patients With Stage III Non-small Cell Lung CancerAutologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed GlioblastomaPOA Prospective RepositoryIntratumoral CAVATAK (CVA21) and Pembrolizumab in Patients With Advanced Melanoma (VLA-011 CAPRA)
P6153
Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor InfiltrationMemantine XR and Pregabalin for Chemotherapy-Induced Peripheral NeuropathyIntegrating Family Caregiver Support Into Cancer Clinical TrialsAn Exploratory Study of Caregiver Burden Among Family Caregivers of Patients With CancerPemetrexed for the Treatment of ChordomaStage IV Surgery Versus Best Medical TherapyStudying Lymph Nodes in Patients With Stage II Colon CancerLymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal CancerCancerLife: Patient-Driven Solution in Cancer CareEffects of Acupuncture on Aromatase Inhibitor-Induced Joint PainA Study Using Tumor-Reactive Autologous Tumor Infiltrating Lymphocytes (TIL) in Metastatic MelanomasA Pilot Study of Pre- and Post-operative Use of Somatuline Depot.Multicenter Selective Lymphadenectomy Trial II (MSLT-II)Multicenter Selective Lymphadenectomy Trial (MSLT)Mitigating Cephalad Fluid Shifts: A NSBRI StudyEvaluation of a Mobile Digital Solution for Cancer Care and ResearchAnti-Tumor Immunity Induced by Cryoablation of Invasive Breast CancersMindful Movement for Breast Cancer SurvivorsThe PREVENTION Trial: Precision Recommendations to Optimize NeurocognitionmSIM: Mobile Simultaneous Aerobic Exercise and Memory Training Intervention for Older Adults With Amnestic Mild Cognitive Impairment
P859
Q58407652-3BACCF1A-6785-4DDC-9AD0-8A7049865150Q61864701-EF5C38E6-0FD2-4021-B81A-06E8432AEB75Q61957512-6B8B0185-C3E3-4BB1-8F74-BF7ED4815B1FQ61957734-644B82DF-EDE9-4D3B-9BF3-BCC4A37DFC4CQ62110609-4A0D1E2C-A0EB-44BC-8CC9-E64506CD7E23Q62110939-8B5BDD63-3392-4A78-8520-EF20F5B69CC6Q63401841-1A1CE007-D202-4702-B2EE-E3EDE08C5FB9Q63534462-2D9EC639-B7AD-41CD-825F-04A7D8F975DEQ63578707-1502D7A1-1CB7-4251-BEB1-1D09FB89DC1A
P6153
Q61864701-7D3F6191-A27F-466E-9997-CCBF53D63453Q62042183-DE83A98E-5AF7-421C-9CA2-76AFB33D53BEQ63229190-3221068C-A31E-42E8-948F-1820C4DB2144Q63229211-5A4AF6F9-32F3-43A8-9A48-9896212C1A32Q64121225-84400195-D73F-4CD4-9EAA-3A494E8D74D8Q64659542-27B52B5B-DC40-4588-A0F2-783465B49611Q64665144-DF303C19-1EB8-4842-889C-01BA6DB6FC71Q64722188-7B4FC77D-7301-4DEA-8A12-670898417663Q64806478-0EE99780-BDB4-4FAE-8982-F8E2E04D0ED2Q65333171-43F3C286-7363-4003-AC1E-A3C50C620CF9Q65347065-C2A3E24A-00CE-4BB2-8095-50CF8B89E745Q65366171-F2002110-4FA8-4371-895E-038740660CD9Q65537846-CE8EBBE2-1205-42BE-83ED-6857C67ABA68Q65539243-2222970E-CA90-48C8-9315-836375BEB36EQ66046497-09311909-418B-4E97-917D-CDED00F09D3AQ66046919-AA5411C2-2A13-40CB-80E8-1932F7DC3F81Q66342554-BAF02DAC-0C42-4245-AAC2-CCF9A42D5C1FQ67128949-88B8583D-D72D-48E5-82E6-20F190BE2239Q74284584-C23C1942-48F5-4B8D-BD0D-9950FA770F3DQ79110477-2D567A4C-B5BD-4774-AD46-137F6CF8C105
P859
description
American nonprofit organization
@en
amerikanische Non-Profit-Organisation
@de
name
John Wayne Cancer Institute
@en
type
label
John Wayne Cancer Institute
@en
prefLabel
John Wayne Cancer Institute
@en
P1297
95-4291515